S. Werness

Discovery and biological evaluation of potent, selective, orally bioavailable, pyrazine-based blockers of the Na(v)1.8 sodium channel with efficacy in a model of neuropathic pain.

Matthew S. Johnson, C. Shieh, James B. Thomas, 2010, Bioorganic & medicinal chemistry.

Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic pain.

Matthew S. Johnson, Dong Liu, C. Shieh, 2008, Bioorganic & medicinal chemistry.

Subtype-selective Na(v)1.8 sodium channel blockers: identification of potent, orally active nicotinamide derivatives.

Matthew S. Johnson, Dong Liu, C. Shieh, 2010, Bioorganic & medicinal chemistry letters.

In Vivo Profile of ICA-27243 [N-(6-Chloro-pyridin-3-yl)-3,4-difluoro-benzamide], a Potent and Selective KCNQ2/Q3 (Kv7.2/Kv7.3) Activator in Rodent Anticonvulsant Models

James O McNamara, J. McNamara, G. Rigdon, 2008, Journal of Pharmacology and Experimental Therapeutics.

Intestinal Metabolism and Bioaccumulation of Sucralose In Adipose Tissue In The Rat

S. Schiffman, S. Werness, V. Bornemann, 2018, Journal of toxicology and environmental health. Part A.

Analysis of rat amylin amide from commercial sources: Identification of a mercury complex.

M. Reily, D. T. Dudley, W. L. Cody, 1991 .

Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory pain.

Matthew S. Johnson, C. Shieh, James B. Thomas, 2008, Journal of medicinal chemistry.

In vitro assessment of oral delivery for hexapeptide endothelin antagonists.

A. Doherty, B. H. Stewart, E. Reyner, 1996, Life sciences.